Idebenone for the treatment of Duchenne muscular dystrophy (Protocol)

Geng J, Dong J, Jiang K, Shen L, Wu T, Ni H, Shi LL, Wang G, Wu H.
The Cochrane Library 2011.
Description of a protocol aiming at assessing efficacy of ibedenone on muscle strength, muscle function, lung function, cardiac function and quality of life for patients with DMD. The MFM is use as primary outcome to assess motor function of patients after 12 months of treatment.

Link

Keywords: Duchenne Muscular Dystrophy, Idebenone, Treatment efficacy, Protocol, Clinical trial

Articles dans les revues scientifiques

Short-TERM Neuromuscular Electrical Stimulation Training of the Tibialis Anterior Did Not Improve Strength and Motor Function in Facioscapulohumeral Muscular Dystrophy Patients

Doix AM, Roeleveld K, Garcia J, Lahaut P, Tanant V, Fournier-Mehouas M, Desnuelle C, Colson SS, Sacconi S Am J Phys Med Rehabil. 2017. 96(4):e56-e63. Prospective study including 10 patients with facioscapulohumeral muscular dystrophy type 1 (FSHD1) and 10 healthy...

read more